Selectively hampered activation of lymph node-resident dendritic cells precedes profound T cell suppression and metastatic spread in the breast cancer sentinel lymph node (Q64276076)

From Wikidata

Jump to navigation Jump to search

scientific article published on 22 May 2019

Language	Label	Description	Also known as
English	Selectively hampered activation of lymph node-resident dendritic cells precedes profound T cell suppression and metastatic spread in the breast cancer sentinel lymph node	scientific article published on 22 May 2019

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31118093%20AND%20SRC:MED&resulttype=core&format=json

28 April 2020

Selectively hampered activation of lymph node-resident dendritic cells precedes profound T cell suppression and metastatic spread in the breast cancer sentinel lymph node (English)

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31118093%20AND%20SRC:MED&resulttype=core&format=json

28 April 2020

0 references

immune suppression

0 references

sentinel lymph node

0 references

0 references

Tanja D de Gruijl

8

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31118093%20AND%20SRC:MED&resulttype=core&format=json

28 April 2020

author name string

Kim M van Pul

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31118093%20AND%20SRC:MED&resulttype=core&format=json

28 April 2020

Ronald J C L M Vuylsteke

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31118093%20AND%20SRC:MED&resulttype=core&format=json

28 April 2020

Rieneke van de Ven

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31118093%20AND%20SRC:MED&resulttype=core&format=json

28 April 2020

Elisabeth A Te Velde

4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31118093%20AND%20SRC:MED&resulttype=core&format=json

28 April 2020

Emiel J Th Rutgers

5

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31118093%20AND%20SRC:MED&resulttype=core&format=json

28 April 2020

Petrousjka M van den Tol

6

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31118093%20AND%20SRC:MED&resulttype=core&format=json

28 April 2020

Hein B A C Stockmann

7

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31118093%20AND%20SRC:MED&resulttype=core&format=json

28 April 2020

language of work or name

0 references

publication date

22 May 2019

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31118093%20AND%20SRC:MED&resulttype=core&format=json

28 April 2020

Journal for Immunotherapy of Cancer

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31118093%20AND%20SRC:MED&resulttype=core&format=json

28 April 2020

7

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31118093%20AND%20SRC:MED&resulttype=core&format=json

28 April 2020

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31118093%20AND%20SRC:MED&resulttype=core&format=json

28 April 2020

133

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31118093%20AND%20SRC:MED&resulttype=core&format=json

28 April 2020

copyright license

Creative Commons Attribution 4.0 International

22 May 2019

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Molecular portraits of human breast tumours

1 reference

https://pubmed.ncbi.nlm.nih.gov/31118093

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selective Modulation of Paracortical Dendritic Cells and T-Lymphocytes in Breast Cancer Sentinel Lymph Nodes

1 reference

https://pubmed.ncbi.nlm.nih.gov/31118093

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sampling tumor-draining lymph nodes for phenotypic and functional analysis of dendritic cells and T cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/31118093

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dendritic cells are dysfunctional in patients with operable breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/31118093

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sentinel node biopsy in breast cancer patients: triple technique as a routine procedure

1 reference

https://pubmed.ncbi.nlm.nih.gov/31118093

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Analysis of dendritic cells in tumor-free and tumor-containing sentinel lymph nodes from patients with breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/31118093

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens

1 reference

https://pubmed.ncbi.nlm.nih.gov/31118093

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Successful live cell harvest from bisected sentinel lymph nodes research report

1 reference

https://pubmed.ncbi.nlm.nih.gov/31118093

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Local administration of granulocyte/macrophage colony-stimulating factor increases the number and activation state of dendritic cells in the sentinel lymph node of early-stage melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/31118093

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mechanisms and functional significance of tumour-induced dendritic-cell defects

1 reference

https://pubmed.ncbi.nlm.nih.gov/31118093

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/31118093

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Profile of immune cells in axillary lymph nodes predicts disease-free survival in breast cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/31118093

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Maturation of dendritic cells and T-cell responses in sentinel lymph nodes from patients with breast carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/31118093

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumour-induced immune modulation of sentinel lymph nodes

1 reference

https://pubmed.ncbi.nlm.nih.gov/31118093

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Presence of mature DC-Lamp+ dendritic cells in sentinel and non-sentinel lymph nodes of breast cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/31118093

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Triple-negative breast cancer: clinical features and patterns of recurrence

1 reference

https://pubmed.ncbi.nlm.nih.gov/31118093

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/31118093

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Genetic alterations and oncogenic pathways associated with breast cancer subtypes

1 reference

https://pubmed.ncbi.nlm.nih.gov/31118093

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Accumulation of regulatory T cells in sentinel lymph nodes is a prognostic predictor in patients with node-negative breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/31118093

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Simultaneous Foxp3 and IDO expression is associated with sentinel lymph node metastases in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/31118093

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metastatic breast cancer: therapeutic options according to molecular subtypes and prior adjuvant therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/31118093

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Toll-like receptor expression and function in human dendritic cell subsets: implications for dendritic cell-based anti-cancer immunotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/31118093

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Superior antigen cross-presentation and XCR1 expression define human CD11c+CD141+ cells as homologues of mouse CD8+ dendritic cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/31118093

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens.

1 reference

https://pubmed.ncbi.nlm.nih.gov/31118093

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterization of human DNGR-1+ BDCA3+ leukocytes as putative equivalents of mouse CD8alpha+ dendritic cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/31118093

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regulatory T cells and breast cancer: implications for immunopathogenesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/31118093

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor-infiltrating CD8+ lymphocytes predict clinical outcome in breast cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/31118093

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterization of four conventional dendritic cell subsets in human skin-draining lymph nodes in relation to T-cell activation

1 reference

https://pubmed.ncbi.nlm.nih.gov/31118093

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metastasis to sentinel lymph nodes in breast cancer is associated with maturation arrest of dendritic cells and poor co-localization of dendritic cells and CD8+ T cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/31118093

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/31118093

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The dendritic cell-regulatory T lymphocyte crosstalk contributes to tumor-induced tolerance

1 reference

https://pubmed.ncbi.nlm.nih.gov/31118093

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The secret ally: immunostimulation by anticancer drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/31118093

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterization of resident and migratory dendritic cells in human lymph nodes

1 reference

https://pubmed.ncbi.nlm.nih.gov/31118093

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Coordinated regulation of myeloid cells by tumours

1 reference

https://pubmed.ncbi.nlm.nih.gov/31118093

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasmacytoid dendritic cells and their therapeutic activity in cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/31118093

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular pathways: involvement of immune pathways in the therapeutic response and outcome in breast cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/31118093

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dual blockade of PD-1 and CTLA-4 combined with tumor vaccine effectively restores T-cell rejection function in tumors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/31118093

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patterns of Recurrence and outcome according to breast cancer subtypes in lymph node-negative disease: results from international breast cancer study group trials VIII and IX.

1 reference

https://pubmed.ncbi.nlm.nih.gov/31118093

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumour-infiltrating CD8+ lymphocytes as an independent predictive factor for pathological complete response to primary systemic therapy in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/31118093

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immune profiles of CD4+ lymphocyte subsets in breast cancer tumor draining lymph nodes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/31118093

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/31118093

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor-infiltrating lymphocytes and response to neoadjuvant chemotherapy with or without carboplatin in human epidermal growth factor receptor 2-positive and triple-negative primary breast cancers

1 reference

https://pubmed.ncbi.nlm.nih.gov/31118093

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Arming the Melanoma Sentinel Lymph Node through Local Administration of CpG-B and GM-CSF: Recruitment and Activation of BDCA3/CD141(+) Dendritic Cells and Enhanced Cross-Presentation

1 reference

https://pubmed.ncbi.nlm.nih.gov/31118093

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Breast Cancer Cell-Derived GM-CSF Licenses Regulatory Th2 Induction by Plasmacytoid Predendritic Cells in Aggressive Disease Subtypes

1 reference

https://pubmed.ncbi.nlm.nih.gov/31118093

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Systemic Monocytic-MDSCs Are Generated from Monocytes and Correlate with Disease Progression in Breast Cancer Patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/31118093

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunology and breast cancer: toward a new way of understanding breast cancer and developing novel therapeutic strategies.

1 reference

https://pubmed.ncbi.nlm.nih.gov/31118093

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical relevance of host immunity in breast cancer: from TILs to the clinic

1 reference

https://pubmed.ncbi.nlm.nih.gov/31118093

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards

1 reference

https://pubmed.ncbi.nlm.nih.gov/31118093

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Melanoma Sequentially Suppresses Different DC Subsets in the Sentinel Lymph Node, Affecting Disease Spread and Recurrence

1 reference

https://pubmed.ncbi.nlm.nih.gov/31118093

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Local Adjuvant Treatment with Low-Dose CpG-B Offers Durable Protection against Disease Recurrence in Clinical Stage I-II Melanoma: Data from Two Randomized Phase II Trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/31118093

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/S40425-019-0605-1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31118093%20AND%20SRC:MED&resulttype=core&format=json

28 April 2020

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31118093%20AND%20SRC:MED&resulttype=core&format=json

28 April 2020

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31118093%20AND%20SRC:MED&resulttype=core&format=json

28 April 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q64276076&oldid=1885623873"